Bristol-Myers Squibb Newsroom

Barclays Adjusts Price Target on Bristol-Myers Squibb to $43 From $42, Maintains Underweight Rating

MT Newswires07:06 ET · Ratings

Bristol-Myers Squibb Says FDA Approves Perioperative Treatment of Neoadjuvant Opdivo in NSCLC

MT Newswires18:05 ET

U.S. Food and Drug Administration Approves Perioperative Treatment of Neoadjuvant Opdivo (Nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Single-Agent Opdivo for Resectable Non-Small Cell Lung Cancer (NSCLC)

Businesswire17:35 ET

Bristol-Myers Squibb Options Spot-On: On October 3rd, 367.35K Contracts Were Traded, With 802.8K Open Interest

Moomoo News16:30 ET

Express News | FDA Approves Neoadjuvant/Adjuvant Nivolumab for Resectable Non-Small Cell Lung Cancer

ReutersOct 3 10:51 ET

Daily short sale tracking: Ambev SA's short volume increased by 8 million, with a short sale ratio of 19%

Moomoo NewsOct 3 09:00 ET

U.S. Tweaks 2025 Medicare Price Negotiation Process

Seeking AlphaOct 3 08:02 ET

Bristol-Myers Squibb To Go Ex-Dividend On October 4th, 2024 With 0.6 USD Dividend Per Share

Moomoo NewsOct 2 21:00 ET

Bristol-Myers Squibb (BMY.US) collaborates with Prime Medicine (PRME.US) to develop innovative cell therapy.

Prime Medicine will receive an upfront payment of $55 million and $55 million in private equity, and is eligible for over $3.5 billion in milestone payments.

Zhitong FinanceOct 2 20:09 ET

Bristol-Myers Squibb Options Spot-On: On October 2nd, 91,629 Contracts Were Traded, With 795.1K Open Interest

Moomoo NewsOct 2 16:30 ET

Bristol-Myers Tops Growth Chart Among S&P 500 Healthcare Stocks in Q3

Seeking AlphaOct 2 10:07 ET

This Is What Whales Are Betting On Bristol-Myers Squibb

BenzingaOct 1 14:16 ET

IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO

BenzingaOct 1 11:40 ET

Bristol-Myers Squibb Company (BMY) Is Driving Growth Through Strategic Acquisitions

Yahoo FinanceOct 1 04:49 ET

Hold Rating on Bristol-Myers Squibb Amid Market Challenges and Strategic Execution Risks

TipRanksOct 1 01:25 ET · Ratings

US Federal Judge Dismisses $6.4 Billion Suit Against Bristol Myers Squibb

MT NewswiresSep 30 14:06 ET

Sector Update: Health Care Stocks Steady Premarket Monday

MT NewswiresSep 30 09:10 ET

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Ahead of Powell's Speech on Economic Outlook

MT NewswiresSep 30 08:59 ET

Traders Consolidate Positions in Final Session for Q3, Driving Cautious Losses for US Equity Futures

MT NewswiresSep 30 08:59 ET

Prime Medicine Shares Rally on Partnership With Bristol Myers Squibb

WSJSep 30 08:51 ET